Search results for "severe acute respiratory syndrome coronavirus 2"

showing 10 items of 547 documents

Potential drawbacks of frequent asymptomatic coronavirus disease 2019 (COVID-19) testing

2020

Microbiology (medical)2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Epidemiologybusiness.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)COVID-19VirologyAsymptomatictestingasymptomatic COVID-19 testingInfectious Diseasesmedicineasymptomaticmedicine.symptombusinessInfection Control & Hospital Epidemiology
researchProduct

Persistent SARS-CoV-2 infection with repeated clinical recurrence in a patient with common variable immunodeficiency

2021

This work was co-financed by the European Union through the Operational Programme of the European Regional Development Fund of Valencia Region (Spain) 2014–2020.

Microbiology (medical)2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)SARS-CoV-2business.industryCommon variable immunodeficiencySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)COVID-19General Medicinemedicine.diseaseVirologyCommon Variable ImmunodeficiencyInfectious DiseasesClinical recurrencemedicineHumansbusinessLetter to the EditorPulmons Malalties
researchProduct

Molecular mimicry in the post-COVID-19 signs and symptoms of neurovegetative disorders?

2021

Many individuals who have severe forms of COVID-19 experience a suite of neurovegetative signs and symptoms (eg, tachycardia) after their recovery, suggesting that the imbalance of the sympathetic-parasympathetic activity of the autonomic nervous system1 could continue for many weeks or months after respiratory symptoms stop. Moreover, a reduction of the parasympathetic tone could have a role in restricting the cholinergic anti-inflammatory pathway, thus favouring hyperinflammation and cytokine storm in the most severe phases of the disease. As reported by Guglielmo Lucchese in The Lancet Microbe,2 SARS-CoV-2 can damage the nervous system via an indirect mechanism, resulting in a high preva…

Microbiology (medical)2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Settore M-PSI/02 - Psicobiologia E Psicologia Fisiologicabusiness.industrySettore BIO/16 - Anatomia UmanaSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Molecular MimicryCOVID-19Signs and symptomsmedicine.disease_causeMicrobiologyMolecular mimicryInfectious DiseasesVirologyImmunologymedicineHumansneurovegetative disordersbusinessThe Lancet. Microbe
researchProduct

Cardiovascular complications in COVID-19:A systematic review and meta-analysis

2020

Microbiology (medical)2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralBioinformaticsBetacoronavirusPandemicMedicineHumansCardiovascular complicationsPandemicsinfektiotauditRetrospective Studiesbiologybusiness.industrySARS-CoV-2COVID-19Covid19komplikaatiotbiology.organism_classificationCardiovascular diseaseInfectious Diseases/dk/atira/pure/core/keywords/uob_covid19Cardiovascular DiseasesMeta-analysissydän- ja verisuonitauditbusinessCoronavirus InfectionsBetacoronavirus
researchProduct

COVID-19 infodemics: the role of mainstream and social media

2021

Microbiology (medical)2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industrySARS-CoV-2Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)COVID-19; Genetic Variation; Health Communication; Humans; Medical Laboratory Personnel; SARS-CoV-2; Social MediaMedia studiesMEDLINECOVID-19Genetic VariationGeneral MedicineInfectious DiseasesHealth CommunicationMedical Laboratory PersonnelCommentaryMainstreamMedicineHumansSocial mediabusinessSocial Media
researchProduct

World Tuberculosis Day 2021 Theme - 'THE CLOCK IS TICKING' - and the world is running out of time to deliver the United Nations General Assembly comm…

2021

Microbiology (medical)2019-20 coronavirus outbreakEconomic growthTuberculosisUnited NationsCoronavirus disease 2019 (COVID-19)General assemblySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Infectious and parasitic diseasesRC109-216Political sciencePandemicwc_505medicineHumansTuberculosisPandemicswa_105SARS-CoV-2COVID-19General Medicinemedicine.diseaseCoronavirusInfectious Diseaseswf_200Theme (narrative)
researchProduct

Lessons from the COVID-19 Pandemic—Unique Opportunities for Unifying, Revamping and Reshaping Epidemic Preparedness of Europe’s Public Health Systems

2020

Microbiology (medical)2019-20 coronavirus outbreakEconomic growthmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Public healthCOVID-19General Medicinelcsh:Infectious and parasitic diseasesInfectious DiseasesSettore MED/38 - PEDIATRIA GENERALE E SPECIALISTICAPreparednessPolitical sciencePandemicmedicinelcsh:RC109-216International Journal of Infectious Diseases
researchProduct

Oral antiseptics against coronavirus: in-vitro and clinical evidence

2021

Background Angiotensin converting enzyme II (ACE2) is the cellular receptor for SARS-CoV-2, so ACE2-expressing cells can act as target cells and are susceptible to infection. ACE2 receptors are highly expressed in the oral cavity so this may be a potential high-risk route for SARS-CoV-2 infection. Furthermore, the virus can be detected in saliva, even before COVID-19 symptoms appear, with the consequent high risk of virus transmission in asymptomatic/pre-symptomatic patients. Reducing oral viral load could lead to a lower risk of transmission via salivary droplets or aerosols and therefore contribute to the control of the pandemic. Aim To evaluate the available evidence testing the in vitro…

Microbiology (medical)2019-20 coronavirus outbreakmedicine.medical_specialtySalivaCoronavirus disease 2019 (COVID-19)coronavirusesSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)virusesMouthwashesCetylpyridiniumReviewmedicine.disease_causeLower riskViruslaw.inventionoral antisepticsRandomized controlled triallawInternal medicinemedicineHumansSalivaLetter to the EditorPandemicsPovidone-IodineCoronavirusMouthSARS-CoV-2Transmission (medicine)business.industryCOVID-19Hydrogen PeroxideGeneral MedicineViral LoadVirologyIn vitroCOVID-19 Drug TreatmentCoronavirusoral rinseInfectious DiseasesSystematic reviewClinical evidenceAnti-Infective Agents LocalCoronavirus InfectionsbusinessViral loadJournal of Hospital Infection
researchProduct

Initial viral load and decay kinetics of SARS-CoV-2 lineage B.1.1.7 in the upper respiratory tract of adults and children

2021

We read with interest the systematic review published by Walsh et al. in the Journal of Infection,1 focusing on the dynamics of SARS-CoV-2 RNA at the upper respiratory tract (URT). In this context, a novel SARS-CoV-2 variant lineage (B.1.1.7), first detected in the UK at the end of 2020 has transmission advantage over other lineages.2 Increased transmissibility of the B.1.1.7 variant has been linked to enhanced ACE2 affinity3 allegedly resulting in higher viral loads in URT, an observation that has been reported in some,3, 4, 5, 6 but not all7 large series published to date. In addition, longer duration of SARS-CoV-2 RNA shedding in URT has been reported in individuals infected by the B.1.1…

Microbiology (medical)Adult2019-20 coronavirus outbreakLineage (genetic)Time FactorsCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralBiologySeverity of Illness IndexBetacoronavirusFecesLimit of DetectionmedicineHumansChildLetter to the EditorAsymptomatic InfectionsPandemicsNoseSARS-CoV-2SputumCOVID-19Viral LoadVirologyVirus SheddingInfectious Diseasesmedicine.anatomical_structureRNA ViralCoronavirus InfectionsViral loadRespiratory tract
researchProduct

Containment of a Large SARS-CoV-2 Outbreak Among Healthcare Workers in a Pediatric Intensive Care Unit.

2020

Objective Healthcare workers (HCWs) are particularly exposed SARS-CoV-2 because they are critical in preventing viral transmission and treating COVID-19 patients. Within HCWs, personnel of intensive care units (ICUs) are at the forefront of treating patients with a severe course of COVID-19 infection and therefore represent an extremely vulnerable group. Thus, our objective is to contribute to establish means of infection control protecting HCWs in the frontline of the current pandemic. Design An outbreak of SARS-CoV-2 was detected and contained in a pediatric ICU (PICU). The first positive case was identified with a point-of-care diagnostic system on site. Real-time PCR-based testing syste…

Microbiology (medical)AdultMalemedicine.medical_specialtyInfectious Disease Transmission Patient-to-ProfessionalSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Health PersonnelPneumonia ViralPsychological interventionIntensive Care Units PediatricHospitals UniversityTertiary Care Centers03 medical and health sciencesBetacoronavirusYoung Adult0302 clinical medicine030225 pediatricsIntensive careGermanyPandemicHealth caremedicineInfection controlHumansPediatrics Perinatology and Child Health030212 general & internal medicinePandemicsPediatric intensive care unitInfection Controlbusiness.industrySARS-CoV-2virus diseasesOutbreakCOVID-19Middle AgedInfectious DiseasesPediatrics Perinatology and Child HealthEmergency medicineQuarantineFemalebusinessCoronavirus InfectionsThe Pediatric infectious disease journal
researchProduct